Concepedia

Lisa Hasvold

LH

26

Publications

2.3K

Citations

20

H-Index

1996

Active since

Affiliations

AbbVie (United States)(Current)

Abbott Fund

Abbott (United States)

Abbott (United Kingdom)

Discovery Laboratories (United States)

Lisa Hasvold is an author at AbbVie (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1996–2020

26

Publications

26

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

Emily J. Faivre, Keith F. McDaniel, Daniel H. Albert et al. · Nature · 2020 · 389 citations

, , +9

Discovery of a Potent and Selective BCL-X <sub>L</sub> Inhibitor with <i>in Vivo</i> Activity

Zhi‐Fu Tao, Lisa Hasvold, Le Wang et al. · ACS Medicinal Chemistry Letters · 2014 · 328 citations · Full text

Palladium(II)-Catalyzed Cyclization of Olefinic Tosylamides

Richard C. Larock, Timothy R. Hightower, Lisa Hasvold et al. · The Journal of Organic Chemistry · 1996 · 280 citations

, , +9

Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity

Milan Bruncko, Le Wang, George S. Sheppard et al. · Journal of Medicinal Chemistry · 2015 · 150 citations · Full text

, , +23

Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells

Andreas Höglund, Lisa M. Nilsson, Somsundar Veppil Muralidharan et al. · Clinical Cancer Research · 2011 · 135 citations

Rows per page

1–5 of 26